AVITA Medical (AVHHL) Net Equity Issued and Repurchased (2020 - 2021)
AVITA Medical's (AVHHL) quarterly Net Equity Issued and Repurchased came in at $69.1 million in Q3 2021, little changed quarter-over-quarter from $69.1 million in Q1 2021.
Powered by 
Analysis
AVITA Medical (AVHHL) Net Equity Issued and Repurchased (2020 - 2021) Analysis & Trends
AVITA Medical (AVHHL) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $69.1 million the latest figure, recorded in Q3 2021.
- For the quarter ending Q3 2021, Net Equity Issued and Repurchased changed N/A year-over-year to $69.1 million; the trailing twelve-month figure through Dec 2025 stood at $138.2 million (changed N/A YoY), and the FY2025 full-year result was $14.8 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased held at $69.1 million in Q3 2021 per AVHHL's latest filing, from $69.1 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $69.1 million in Q1 2021 and bottomed at $1000.0 in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.62 Bn | 179.02 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.22 Bn | 119.01 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.38 Bn | 109.56 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 104.98 Bn | 101.51 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.67 Bn | 66.13 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.77 Bn | 45.52 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.01 Bn | 32.56 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | - |
| 9 | Steris | 21.17 Bn | 20.69 Bn | 684.20 Mn | - |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 69.11 Mn |
| Mar 31, 2021 | 69.11 Mn |
| Mar 31, 2020 | 1,000.00 |